Breaking India News Today | In-Depth Reports & Analysis – IndiaNewsWeekBreaking India News Today | In-Depth Reports & Analysis – IndiaNewsWeek
  • Home
  • Nation
  • Politics
  • Economy
  • Sports
  • Entertainment
  • International
  • Technology
  • Auto News
Reading: Controversial Gene-Editor Faces Comeback After Prison for Editing Babies
Share
Breaking India News Today | In-Depth Reports & Analysis – IndiaNewsWeekBreaking India News Today | In-Depth Reports & Analysis – IndiaNewsWeek
  • Home
  • Nation
  • Politics
  • Economy
  • Sports
  • Entertainment
  • International
  • Technology
  • Auto News
© 2024 All Rights Reserved | Powered by India News Week
Trending Now: Stay updated with the latest breaking news from India and around the world
He Went to Prison for Gene-Editing Babies. Now He’s Planning to Do It Again
Breaking India News Today | In-Depth Reports & Analysis – IndiaNewsWeek > Technology > Controversial Gene-Editor Faces Comeback After Prison for Editing Babies
Technology

Controversial Gene-Editor Faces Comeback After Prison for Editing Babies

Technology Desk By Technology Desk January 20, 2026 5 Min Read
Share
SHARE

nervous-looking He Jiankui took the stage at a scientific conference in Hong Kong. A hush settled over the packed auditorium as the soft-spoken Chinese scientist adjusted his microphone and confirmed the circulating media reports: He had created the world’s first gene-edited babies.

Three little girls were born with modifications to their genomes that were intended to protect them against HIV. The changes he’d made to their DNA were permanent and heritable, meaning they could be passed down to future generations.

A Chinese court sent him to prison for three years, and the Chinese government banned genome editing for reproductive purposes. Now He is trying to reestablish himself as a man out to change history.

Since his release in 2022, He says, he’s worked on a gene therapy for boys with Duchenne muscular dystrophy. He has yet to publish or share any results publicly, but he claims that a pharmaceutical company has taken on his Duchenne research and that funders are eager to help him continue his work. And He, who has set up an independent lab in south Beijing, recently started talking again about human embryo editing—this time to prevent Alzheimer’s. With germline editing prohibited in nearly every country including the United States, his path forward is unclear.

Through it all, He has documented his life on social media. He has posted about his failed romance with self-styled “biotech Barbie” Cathy Tie, a Canadian former Thiel fellow and cofounder of a human embryo editing startup. A condition of this interview was that WIRED refer to He as a “pioneer of gene editing,” but he has more colorfully referred to himself on X as “Chinese Darwin,” “Oppenheimer in China,” and “China’s Frankenstein.”

He often posts photos of himself in a crisp lab coat, posing alone near scientific equipment. One glaringly empty lab shot comes with the text “I did not violate ethics, I overturned it.” More recently he dropped the austere look and posted an image of himself seated on a giant throne with prehistoric animals at his feet, a rainbow beaming down on his crown, and a double helix adorning his purple robe.

WIRED spoke with He about designer babies—the ones already born and the ones he hopes to eventually produce. This interview has been edited for length and clarity.

Emily Mullin: Back in 2018 the scientific consensus was that gene editing was not a mature technology. Do you think it’s mature now?

He Jiankui: Anyone who is the first in the world, no one can say it’s mature. The Wright brothers who made the first flight, was it mature? Of course not, but they made history.

I’m lucky that Lulu, Nana, and the third girl were healthy; they’re normal. We have observed them for seven, eight years now. So I think it’s time to move on to hundreds of gene-edited babies. We should give a trial to maybe 300 now.

Do you keep in touch with the parents of the three babies?

Yes, we have regular contact.

And everything seems fine?

Yeah, they go to primary school. Their family is very happy with it.

Have their parents told them that they were gene-edited?

No.

What is your new lab focusing on?

The new lab is germline gene editing—embryo gene editing—and it is focusing on trying to prevent Alzheimer’s disease.

What genes are you working on?

The APP-A673T mutation. This mutation was identified in the population in Iceland. People with this mutation are free of Alzheimer’s and even live longer. They’re healthy and normal. So we want to introduce the mutation to the next generation, so they will have the same mutation as Icelandic people and be free of Alzheimer’s.

Are you currently working with human embryos?

TAGGED:EducationTechnology
Share This Article
Twitter Copy Link
Previous Article Ishan Kishan returns, Iyer to miss out; India's probable Playing XI for IND vs NZ 1st T20I India’s Predicted XI for 1st T20I: Ishan Kishan Back, Iyer Out
Next Article Toyota Urban Cruiser Ebella EV launched in India: Price, features, range, and more Toyota Urban Cruiser Ebella EV Debuts in India: Pricing, Features, Range, and More
Leave a comment Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Latest News

Brokerages favour domestic growth, capex-led stocks in Samvat 2083

You are a professional news headline editor. Rewrite the following headline into a unique, engaging, SEO-friendly English news title. Rules: Maximum 16 words. Output ONLY the rewritten headline. No quotes, no explanations, no instructions.Original: Brokerages favour domestic growth, capex-led stocks in Samvat 2083Rewritten headline:

November 3, 2026
In Pictures: US midterm elections in 20 photos

Write one original, SEO-friendly English news headline for an Indian audience based on this source title: In Pictures: US midterm elections in 20 photosRules: factual and specific, include the key entity or number, 8-14 words, no clickbait, no quotation marks, output ONLY the headline text.

November 3, 2026
R&D-focused companies deliver 23.5% returns, outperform NSE 500: Monarch AIF

You are a professional news headline editor. Rewrite the following headline into a unique, engaging, SEO-friendly English news title. Rules: Maximum 16 words. Output ONLY the rewritten headline. No quotes, no explanations, no instructions.Original: R&D-focused companies deliver 23.5% returns, outperform NSE 500: Monarch AIFRewritten headline:

November 3, 2026
Q2 Results 03rd Nov Oct Live: SBI, NSE, Bajaj Finserv, Solar Ind, Fortis, Gujarat Fluoro, Bajaj Holdings, Lloyds Metals & Energy, Lupin, MCX, Emcure Pharma, AIA Engineering, Zydus Wellness to announce Q2 results, KRBL, ITC, MARICO, MobiKwik shares gain, Petronet LNG, Wockhardt, KEC International shares decline

You are a professional news headline editor. Rewrite the following headline into a unique, engaging, SEO-friendly English news title. Rules: Maximum 16 words. Output ONLY the rewritten headline. No quotes, no explanations, no instructions.Original: Q2 Results 03rd Nov Oct Live: SBI, NSE, Bajaj Finserv, Solar Ind, Fortis, Gujarat Fluoro, Bajaj Holdings, Lloyds Metals & Energy, Lupin, MCX, Emcure Pharma, AIA Engineering, Zydus Wellness to announce Q2 results, KRBL, ITC, MARICO, MobiKwik shares gain, Petronet LNG, Wockhardt, KEC International shares declineRewritten headline:

November 3, 2026
TVS Holdings allotted shares in Home Credit India Finance as part of rights issue

You are a professional news headline editor. Rewrite the following headline into a unique, engaging, SEO-friendly English news title. Rules: Maximum 16 words. Output ONLY the rewritten headline. No quotes, no explanations, no instructions.Original: TVS Holdings allotted shares in Home Credit India Finance as part of rights issueRewritten headline:

November 3, 2026
Broker’s call: PB Fintech (Buy)

You are a professional news headline editor. Rewrite the following headline into a unique, engaging, SEO-friendly English news title. Rules: Maximum 16 words. Output ONLY the rewritten headline. No quotes, no explanations, no instructions.Original: Broker’s call: PB Fintech (Buy)Rewritten headline:

November 2, 2026

You Might Also Like

Panasonic Z95A OLED TV Review: Searing Brightness and Colors
Technology

Panasonic Z95A OLED TV Review: Stunning Brightness and Vivid Colors Shine Bright

5 Min Read
Great learning survey: 67% of engineers say their roles evolving with AI
Technology

67% of Engineers Adapt to Evolving Roles in AI Revolution

5 Min Read
Confluent boosts real-time delivery for swiggy’s millions of consumers
Technology

Confluent Enhances Real-Time Delivery for Swiggy’s Millions of Users

3 Min Read
new Apple iOS update is wrecking my iPhone
Technology

Latest Apple iOS Update Causing Major Issues for iPhone Users

8 Min Read

About IndiaNewsWeek

IndiaNewsWeek is your trusted source for breaking news, in-depth analysis, and comprehensive coverage of India and the world. We deliver accurate, timely reporting across politics, economy, sports, entertainment, and technology.

contact@indianewsweek.com

Quick Links

  • Nation
  • Politics
  • Economy
  • International
  • Sports
  • Entertainment

More Sections

  • Technology
  • Auto News
  • Education
  • About Us
  • Contact
  • Privacy Policy

Stay Connected

Follow us on social media for the latest updates and breaking news.

Facebook
X (Twitter)
YouTube
Follow US
© 2026 IndiaNewsWeek. All Rights Reserved.
Welcome Back!

Sign in to your account

Lost your password?